Annual SGA
$40.75 M
+$5.92 M+16.99%
December 31, 2024
Summary
- As of March 9, 2025, KROS annual SGA is $40.75 million, with the most recent change of +$5.92 million (+16.99%) on December 31, 2024.
- During the last 3 years, KROS annual SGA has risen by +$19.42 million (+91.06%).
- KROS annual SGA is now at all-time high.
Performance
KROS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$10.66 M
+$845.00 K+8.60%
December 31, 2024
Summary
- As of March 9, 2025, KROS quarterly SGA is $10.66 million, with the most recent change of +$845.00 thousand (+8.60%) on December 31, 2024.
- Over the past year, KROS quarterly SGA has increased by +$845.00 thousand (+8.60%).
- KROS quarterly SGA is now at all-time high.
Performance
KROS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.99 B
-$187.35 M-10.42%
December 31, 2024
Summary
- As of March 9, 2025, KROS TTM SGA is -$1.99 billion, with the most recent change of -$187.35 million (-10.42%) on December 31, 2024.
- Over the past year, KROS TTM SGA has dropped by -$2.03 billion (-5166.77%).
- KROS TTM SGA is now -10006.20% below its all-time high of -$19.65 million.
Performance
KROS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
KROS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.0% | +8.6% | -5166.8% |
| 3 y3 years | +91.1% | +76.8% | -9410.2% |
| 5 y5 years | +1180.0% | +899.5% | -10000.0% |
KROS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.1% | at high | +76.8% | -375.1% | at low |
| 5 y | 5-year | at high | +1180.0% | at high | +899.5% | <-9999.0% | at low |
| alltime | all time | at high | +2479.4% | at high | +2072.1% | <-9999.0% | at low |
Keros Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $40.75 M(+17.0%) | $10.66 M(+8.6%) | $40.75 M(+4.0%) |
| Sep 2024 | - | $9.82 M(-1.4%) | $39.19 M(+1.7%) |
| Jun 2024 | - | $9.96 M(-3.4%) | $38.52 M(+3.1%) |
| Mar 2024 | - | $10.31 M(+13.2%) | $37.36 M(+7.3%) |
| Dec 2023 | $34.83 M(+26.6%) | $9.11 M(-0.5%) | $34.83 M(+6.1%) |
| Sep 2023 | - | $9.15 M(+3.9%) | $32.82 M(+7.2%) |
| Jun 2023 | - | $8.80 M(+13.2%) | $30.61 M(+4.6%) |
| Mar 2023 | - | $7.78 M(+9.7%) | $29.25 M(+6.3%) |
| Dec 2022 | $27.52 M(+29.0%) | $7.09 M(+2.2%) | $27.52 M(+4.0%) |
| Sep 2022 | - | $6.94 M(-6.8%) | $26.46 M(+6.3%) |
| Jun 2022 | - | $7.45 M(+23.1%) | $24.89 M(+7.7%) |
| Mar 2022 | - | $6.05 M(+0.2%) | $23.10 M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $21.33 M(+66.7%) | $6.03 M(+12.5%) | $21.33 M(+12.8%) |
| Sep 2021 | - | $5.37 M(-5.2%) | $18.91 M(+10.6%) |
| Jun 2021 | - | $5.66 M(+32.4%) | $17.10 M(+13.3%) |
| Mar 2021 | - | $4.27 M(+18.2%) | $15.09 M(+17.9%) |
| Dec 2020 | $12.80 M(+301.9%) | $3.62 M(+1.8%) | $12.80 M(+24.9%) |
| Sep 2020 | - | $3.55 M(-2.7%) | $10.25 M(+33.7%) |
| Jun 2020 | - | $3.65 M(+84.6%) | $7.67 M(+64.2%) |
| Mar 2020 | - | $1.98 M(+85.3%) | $4.67 M(+46.7%) |
| Dec 2019 | $3.18 M(+101.5%) | $1.07 M(+9.8%) | $3.18 M(+50.4%) |
| Sep 2019 | - | $972.00 K(+48.6%) | $2.12 M(+84.9%) |
| Jun 2019 | - | $654.00 K(+33.2%) | $1.15 M(+133.2%) |
| Mar 2019 | - | $491.00 K | $491.00 K |
| Dec 2018 | $1.58 M | - | - |
FAQ
- What is Keros Therapeutics annual SGA?
- What is the all time high annual SGA for Keros Therapeutics?
- What is Keros Therapeutics annual SGA year-on-year change?
- What is Keros Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Keros Therapeutics?
- What is Keros Therapeutics quarterly SGA year-on-year change?
- What is Keros Therapeutics TTM SGA?
- What is the all time high TTM SGA for Keros Therapeutics?
- What is Keros Therapeutics TTM SGA year-on-year change?
What is Keros Therapeutics annual SGA?
The current annual SGA of KROS is $40.75 M
What is the all time high annual SGA for Keros Therapeutics?
Keros Therapeutics all-time high annual SGA is $40.75 M
What is Keros Therapeutics annual SGA year-on-year change?
Over the past year, KROS annual SGA has changed by +$5.92 M (+16.99%)
What is Keros Therapeutics quarterly SGA?
The current quarterly SGA of KROS is $10.66 M
What is the all time high quarterly SGA for Keros Therapeutics?
Keros Therapeutics all-time high quarterly SGA is $10.66 M
What is Keros Therapeutics quarterly SGA year-on-year change?
Over the past year, KROS quarterly SGA has changed by +$845.00 K (+8.60%)
What is Keros Therapeutics TTM SGA?
The current TTM SGA of KROS is -$1.99 B
What is the all time high TTM SGA for Keros Therapeutics?
Keros Therapeutics all-time high TTM SGA is -$19.65 M
What is Keros Therapeutics TTM SGA year-on-year change?
Over the past year, KROS TTM SGA has changed by -$2.03 B (-5166.77%)